Variant report
Variant | nsv975077 |
---|---|
Chromosome Location | chr10:93126653-93133345 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547936684 | chr10:93126674-93126675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs144388072 | chr10:93126685-93126686 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536939082 | chr10:93126688-93126689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556870614 | chr10:93126712-93126713 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148360822 | chr10:93126713-93126714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs141512867 | chr10:93126770-93126771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552708986 | chr10:93126786-93126787 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150752294 | chr10:93126807-93126808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370281208 | chr10:93126832-93126833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs80155351 | chr10:93126853-93126854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs74740771 | chr10:93126854-93126855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542534185 | chr10:93126870-93126871 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544902712 | chr10:93126906-93126907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181243615 | chr10:93126930-93126931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139223323 | chr10:93126969-93126970 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546934730 | chr10:93126974-93126975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560290983 | chr10:93127003-93127004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs61386275 | chr10:93127013-93127014 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs371480345 | chr10:93127080-93127081 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144023583 | chr10:93127102-93127103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567900680 | chr10:93127111-93127112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs369551227 | chr10:93127117-93127118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536874781 | chr10:93127135-93127136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs57540022 | chr10:93127150-93127151 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs570691727 | chr10:93127180-93127181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs74150659 | chr10:93127235-93127236 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs552885571 | chr10:93127250-93127251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572796776 | chr10:93127253-93127254 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145942459 | chr10:93127256-93127257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186071922 | chr10:93127274-93127275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575882623 | chr10:93127278-93127279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547085374 | chr10:93127290-93127291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139788569 | chr10:93127291-93127292 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs578162950 | chr10:93127433-93127434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540620362 | chr10:93127483-93127484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571839780 | chr10:93127494-93127495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562595466 | chr10:93127504-93127505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540642667 | chr10:93127546-93127547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149758219 | chr10:93127548-93127549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs60667168 | chr10:93127583-93127584 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs549046251 | chr10:93127586-93127587 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562615203 | chr10:93127618-93127619 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564125949 | chr10:93127628-93127629 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11595828 | chr10:93127732-93127733 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531706719 | chr10:93127740-93127741 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370935050 | chr10:93127778-93127779 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532848307 | chr10:93127816-93127817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565598757 | chr10:93127819-93127820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114478293 | chr10:93127820-93127821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12264143 | chr10:93127873-93127874 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:93113800-93136600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr10:93126200-93127000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr10:93126200-93127200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr10:93126200-93127400 | Enhancers | HUVEC | blood vessel |
5 | chr10:93126400-93126800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr10:93126400-93127000 | Enhancers | Osteobl | bone |
7 | chr10:93126400-93127200 | Enhancers | Fetal Brain Male | brain |
8 | chr10:93126400-93127600 | Enhancers | Fetal Heart | heart |
9 | chr10:93126400-93128000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr10:93126400-93128000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr10:93126400-93128000 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr10:93126400-93128600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr10:93126600-93127200 | Enhancers | Fetal Brain Female | brain |
14 | chr10:93126600-93127400 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr10:93126600-93127800 | Enhancers | HSMM | muscle |
16 | chr10:93126800-93127600 | Enhancers | HSMMtube | muscle |
17 | chr10:93126800-93130200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr10:93127200-93127400 | Enhancers | NH-A | brain |
19 | chr10:93127600-93127800 | Flanking Active TSS | Fetal Heart | heart |
20 | chr10:93127800-93128200 | Enhancers | Fetal Heart | heart |
21 | chr10:93128200-93129200 | Bivalent Enhancer | Fetal Heart | heart |